Rebecca G Wells

Rebecca Wells is a Professor of Medicine with a secondary appointment in Bioengineering at the University of Pennsylvania, where she has been on the faculty for more than 20 years. She received a medical degree from Johns Hopkins University and did postdoctoral research training at Brigham and Women's Hospital/Harvard University and the Whitehead Institute. Her lab studies the intersection between the extracellular matrix and mechanics as applied to wound healing, using the liver and biliary tree as model tissues.

W. Ray Kim

W. Ray Kim, MD, MBA, FAASLD, currently serves as Professor of Medicine at Mayo Clinic Arizona, and previously served as Professor of Medicine and Chief, Division of Gastroenterology and Hepatology in the Department of Medicine at Stanford University. Dr. Kim received his MD degree from Seoul National University and his MBA from the University of Pennsylvania.

Lisa B. VanWagner

Lisa VanWagner MD MSc FAST FAHA is Associate Professor of Medicine and Director of Clinical Research in the Division of Digestive and Liver Diseases at the University of Texas Southwestern Medical Center in Dallas, Texas. Her clinical research lab utilizes health services research methods to define and characterize cardiometabolic disease risk prediction, prevention, and treatment approaches in patients with chronic liver disease particularly surrounding liver transplantation. She has published over 150 peer-reviewed manuscripts and received continuous NIH funding since 2012. Dr.

Marina Serper

Dr. Serper is Associate Professor of Medicine at the University of Pennsylvania. She is a transplant hepatologist with expertise in epidemiology, health services research, patient-oriented research and digital health. Her research works studying clinical outcomes in cirrhosis and designing interventions to improve health outcomes of patients with chronic advanced liver disease, alcohol-associated liver disease, and liver transplantation.

Neil Mehta

I am a Transplant Hepatologist and Associate Clinical Professor at UCSF. I am the Director of our Liver Cancer Multidisciplinary Program as well as the Medical Director of our Live Donor Liver Transplantation program. My research focus is primarily on selection criteria and liver transplant outcomes for patients with HCC including with respect to down-staging, incorporation of biomarkers, and improving transplant access.

Timucin Taner

Dr. Taner is a Professor of Surgery and Consultant in Immunology at Mayo Clinic, Rochester. He is the Chair of the Division of Transplantation Surgery, and the surgical director of liver transplantation of both the adult and pediatric programs at the same institution. His clinical practice involves liver transplantation, living donor hepatectomies and nephrectomies. His research focuses on liver transplant immunobiology, investigating the interaction between the liver allografts and the host immune responses. He is the current co-Editor-in-Chief of Liver Transplantation.

Andres Cardenas

Dr. Cárdenas is a Staff Member and Consultant of the Institute of Digestive Diseases and Metabolism at Hospital Clinic and Accredited Professor of Medicine (Catalan Agency for Quality Assessment) with the University of Barcelona. He pursued his Residency and Fellowship in Internal Medicine, Gastroenterology, Hepatology at Boston University and Harvard Medical School at Beth Israel Deaconess Medical Center in Boston. Dr. Cardenas is Board Certified in Internal Medicine, Gastroenterology and Hepatology by the American Board of Internal Medicine.

Subscribe to